<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39349752</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1076</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>European journal of pediatrics</Title><ISOAbbreviation>Eur J Pediatr</ISOAbbreviation></Journal><ArticleTitle>In-hospital unfavorable outcomes of MIS-C during 2020-2022: a systematic review.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00431-024-05787-x</ELocationID><Abstract><AbstractText Label="UNLABELLED">Studies on the severity in multisystem inflammatory syndrome in children (MIS-C) show heterogeneous results and may not reflect a global perspective. This systematic review aims to estimate the frequency of in-hospital unfavorable outcomes in patients with MIS-C over the 3 years since the onset of the SARS-CoV-2 pandemic. A systematic search was conducted in Medline, Scopus, Embase, Cochrane, Web of Science, Scielo, and preprint repositories until December 15, 2022. Study selection and data extraction were evaluated independently. The primary outcomes were intensive care unit (ICU) admission, invasive mechanical ventilation (IMV), and death. Additionally, we evaluated cardiovascular-related outcomes. We performed a random-effects model meta-analysis and assessed the certainty of the evidence. Fifty-seven studies (n = 13 254) were included. The frequency of ICU admission was 44.7% (95% CI 38.8-50.7), 11.9% for IMV (95% CI 9.6-14.4), and 2.0% for death (95% CI 1.3-3.0). The requirement of vasoactive/inotropic drugs was 40.1% (95% CI 35.9-44.4), 7.9% for coronary aneurysm (95% CI 4.1-12.7), 30.7% for decreased left ventricle ejection fraction (LVEF) (95% CI 26.3-35.4), and 29.7% for myocarditis (95% CI 18.4-42.4). We assess the included evidence as being of very low certainty. Finally, excess COVID-19 mortality by country and the diagnostic criteria for MIS-C (CDC compared to WHO) were associated with a higher frequency of ICU admissions. The year of study conduction (2022 compared to 2020) was associated with a lower frequency of IMV.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The frequency of in-hospital unfavorable outcomes in patients with MIS-C was high. Well-designed studies are needed to explore other heterogeneity sources.</AbstractText><AbstractText Label="PROTOCOL REGISTRATION" NlmCategory="BACKGROUND">CRD42021284878.</AbstractText><AbstractText Label="WHAT IS KNOWN" NlmCategory="BACKGROUND">• Multisystem inflammatory syndrome in children (MIS-C) is a serious post-infectious condition linked to SARS-CoV-2. Studies on the severity of MIS-C show heterogeneous results. These findings may not be representative of the reality in other regions, making it challenging to draw generalizable conclusions.</AbstractText><AbstractText Label="WHAT IS NEW" NlmCategory="BACKGROUND">• Over the 3 years since the onset of the SARS-CoV-2 pandemic, our systematic review has shown that the frequency of in-hospital unfavorable outcomes in patients with MIS-C is high, with a very low certainty of the evidence. Our results reflect the reality from a global perspective, across different countries with varying income levels. • The main sources of heterogeneity in the frequency of severe outcomes could be explained by the excess mortality due to COVID-19 in each country, the type of diagnostic criteria for MIS-C, and the year the study was conducted.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alvarado-Gamarra</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7266-5808</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Perú. galvaradogamarra@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigación Nutricional, Lima, Perú. galvaradogamarra@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Red de Eficacia Clínica y Sanitaria, REDECS, Lima, Perú. galvaradogamarra@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alcalá-Marcos</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9697-0914</Identifier><AffiliationInfo><Affiliation>Cardiology. Instituto Nacional Cardiovascular "Carlos Alberto Peschiera Carrillo" - INCOR, Lima, Perú.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balmaceda-Nieto</LastName><ForeName>Pía</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-7534-536X</Identifier><AffiliationInfo><Affiliation>Red de Eficacia Clínica y Sanitaria, REDECS, Lima, Perú.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visconti-Lopez</LastName><ForeName>Fabriccio J</ForeName><Initials>FJ</Initials><Identifier Source="ORCID">0000-0002-8056-2112</Identifier><AffiliationInfo><Affiliation>Sociedad Científica de Estudiantes de Medicina - UPC, Lima, Perú.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Balarezo</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-7169-2540</Identifier><AffiliationInfo><Affiliation>Red de Eficacia Clínica y Sanitaria, REDECS, Lima, Perú.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Central del Ecuador, Quito, Ecuador.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morán-Mariños</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-1353-0540</Identifier><AffiliationInfo><Affiliation>Unidad de Investigación en Bibliometría, Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Perú.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velásquez-Rimachi</LastName><ForeName>Victor</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-9350-7171</Identifier><AffiliationInfo><Affiliation>Grupo de Investigación Neurociencias, Metabolismo, Efectividad Clínica y Sanitaria (NEMECS), Universidad Científica del Sur, Lima, Perú.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chavez-Malpartida</LastName><ForeName>Sandra S</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0003-3519-5189</Identifier><AffiliationInfo><Affiliation>Red de Eficacia Clínica y Sanitaria, REDECS, Lima, Perú.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Perú.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alva-Díaz</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3584-7298</Identifier><AffiliationInfo><Affiliation>Grupo de Investigación Neurociencias, Metabolismo, Efectividad Clínica y Sanitaria (NEMECS), Universidad Científica del Sur, Lima, Perú.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Servicio de Neurología, Departamento de Medicina y Oficina de Apoyo a la Docencia e Investigación (OADI), Hospital Daniel Alcides Carrión, Callao, Perú.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Pediatr</MedlineTA><NlmUniqueID>7603873</NlmUniqueID><ISSNLinking>0340-6199</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Critical care outcomes</Keyword><Keyword MajorTopicYN="N">Fatal outcome</Keyword><Keyword MajorTopicYN="N">Pediatric multisystem inflammatory disease, COVID-19 related</Keyword><Keyword MajorTopicYN="N">Pediatrics (Source: MeSH terms)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39349752</ArticleId><ArticleId IdType="doi">10.1007/s00431-024-05787-x</ArticleId><ArticleId IdType="pii">10.1007/s00431-024-05787-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Miller AD, Yousaf AR, Bornstein E et al (2022) Multisystem inflammatory syndrome in children during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta and omicron variant circulation-United States, July 2021-January 2022. Clin Infect Dis 75:S303-s307. https://doi.org/10.1093/cid/ciac471</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac471</ArticleId><ArticleId IdType="pubmed">35684958</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Tang K, Irfan O et al (2022) Epidemiology, clinical features, and outcomes of multisystem inflammatory syndrome in children (MIS-C) and adolescents-a live systematic review and meta-analysis. Curr Pediatr Rep 10:19–30. https://doi.org/10.1007/s40124-022-00264-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40124-022-00264-1</ArticleId><ArticleId IdType="pubmed">35540721</ArticleId><ArticleId IdType="pmc">9072767</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruvinsky S, Voto C, Roel M et al (2022) Multisystem inflammatory syndrome temporally related to COVID-19 in children from Latin America and the Caribbean Region: a systematic review with a meta-analysis of data from regional surveillance systems. Front Pediatr 10:881765. https://doi.org/10.3389/fped.2022.881765</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.881765</ArticleId><ArticleId IdType="pubmed">35547540</ArticleId><ArticleId IdType="pmc">9082071</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen A, Miller AD, Zambrano LD et al (2021) Demographic and clinical factors associated with death among persons &lt;21 years old with multisystem inflammatory syndrome in children-United States, February 2020-March 2021. Open Forum Infect Dis 8:ofab388. https://doi.org/10.1093/ofid/ofab388</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab388</ArticleId><ArticleId IdType="pubmed">34409123</ArticleId><ArticleId IdType="pmc">8364981</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuhara J, Masuda K, Watanabe K et al (2023) Longitudinal cardiac outcomes of multisystem inflammatory syndrome in children: a systematic review and meta-analysis. Pediatr Cardiol 44:892–907. https://doi.org/10.1007/s00246-022-03052-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-022-03052-2</ArticleId><ArticleId IdType="pubmed">36416893</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwalb A, Armyra E, Méndez-Aranda M et al (2022) COVID-19 in Latin America and the Caribbean: two years of the pandemic. J Intern Med 292:409–427. https://doi.org/10.1111/joim.13499</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13499</ArticleId><ArticleId IdType="pubmed">35411985</ArticleId></ArticleIdList></Reference><Reference><Citation>Haldane V, De Foo C, Abdalla SM et al (2021) Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries. Nat Med 27:964–980. https://doi.org/10.1038/s41591-021-01381-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01381-y</ArticleId><ArticleId IdType="pubmed">34002090</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos MO, Gonçalves LC, Silva PAN et al (2022) Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes. J Pediatr (Rio J) 98:338–349. https://doi.org/10.1016/j.jped.2021.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jped.2021.08.006</ArticleId><ArticleId IdType="pubmed">34863701</ArticleId></ArticleIdList></Reference><Reference><Citation>Snooks K, Scanlon MC, Remy KE et al (2022) Characteristics and outcomes of critically Ill children with multisystem inflammatory syndrome. Pediatr Crit Care Med 23:e530–e535. https://doi.org/10.1097/pcc.0000000000003054</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/pcc.0000000000003054</ArticleId><ArticleId IdType="pubmed">35994614</ArticleId><ArticleId IdType="pmc">9624236</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagiannidis C, Sander LE, Mall MA et al (2022) Incidence and outcomes of SARS-CoV-2-associated PIMS in Germany: a nationwide analysis. Infection 50:1627–1629. https://doi.org/10.1007/s15010-022-01877-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01877-w</ArticleId><ArticleId IdType="pubmed">35773555</ArticleId><ArticleId IdType="pmc">9246358</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz Ciftdogan D, Ekemen Keles Y, Cetin BS et al (2022) COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group. Eur J Pediatr 181:2031–2043. https://doi.org/10.1007/s00431-022-04390-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04390-2</ArticleId><ArticleId IdType="pubmed">35129668</ArticleId><ArticleId IdType="pmc">8819197</ArticleId></ArticleIdList></Reference><Reference><Citation>Flood J, Shingleton J, Bennett E et al (2021) Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): prospective, national surveillance, United Kingdom and Ireland, 2020. Lancet Reg Health Eur 3:100075. https://doi.org/10.1016/j.lanepe.2021.100075</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100075</ArticleId><ArticleId IdType="pubmed">34027512</ArticleId><ArticleId IdType="pmc">8132575</ArticleId></ArticleIdList></Reference><Reference><Citation>Relvas-Brandt LA, Gava C, Camelo FS et al (2021) Multisystem inflammatory syndrome in children: a cross-sectional study of cases and factors associated with deaths during the COVID-19 pandemic in Brazil, 2020. Epidemiol Serv Saude 30:e2021267. https://doi.org/10.1590/s1679-49742021000400005</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s1679-49742021000400005</ArticleId><ArticleId IdType="pubmed">34755796</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustos BR, Jaramillo-Bustamante JC, Vasquez-Hoyos P et al (2021) Pediatric inflammatory multisystem syndrome associated with SARS-CoV-2: a case series quantitative systematic review. Pediatr Emerg Care 37:44–47. https://doi.org/10.1097/pec.0000000000002306</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/pec.0000000000002306</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams V, Dash N, Suthar R et al (2022) Clinicolaboratory profile, treatment, intensive care needs, and outcome of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2: a systematic review and meta-analysis. J Pediatr Intensive Care 11:1–12. https://doi.org/10.1055/s-0040-1719173</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1719173</ArticleId><ArticleId IdType="pubmed">35178272</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhar D, Dey T, Samim MM et al (2022) Systemic inflammatory syndrome in COVID-19-SISCoV study: systematic review and meta-analysis. Pediatr Res 91:1334–1349. https://doi.org/10.1038/s41390-021-01545-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-021-01545-z</ArticleId><ArticleId IdType="pubmed">34006982</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Yin L, Patel J et al (2021) The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: a meta-analysis. J Med Virol 93:4358–4369. https://doi.org/10.1002/jmv.26951</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26951</ArticleId><ArticleId IdType="pubmed">33739452</ArticleId><ArticleId IdType="pmc">8250955</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamad Saied M, van der Griend L, van Straalen JW et al (2023) The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysis. Pediatr Rheumatol Online J 21:80. https://doi.org/10.1186/s12969-023-00848-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-023-00848-1</ArticleId><ArticleId IdType="pubmed">37550719</ArticleId><ArticleId IdType="pmc">10405572</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Berger NA, Kaelber DC et al (2022) Incidence rates and clinical outcomes of SARS-CoV-2 infection with the omicron and delta variants in children younger than 5 years in the US. JAMA Pediatr 176:811–813. https://doi.org/10.1001/jamapediatrics.2022.0945</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.0945</ArticleId><ArticleId IdType="pubmed">35363246</ArticleId><ArticleId IdType="pmc">8976262</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Almeida FJ, Baillie JK et al (2023) International pediatric COVID-19 severity over the course of the pandemic. JAMA Pediatr 177:1073–1084. https://doi.org/10.1001/jamapediatrics.2023.3117</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2023.3117</ArticleId><ArticleId IdType="pubmed">37603343</ArticleId><ArticleId IdType="pmc">10442787</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. https://doi.org/10.1371/journal.pmed.1000097</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId><ArticleId IdType="pmc">2707599</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J et al (2023) Cochrane handbook for systematic reviews of interventions version 6.4 (updated August 2023). Cochrane. Available from https://www.training.cochrane.org/handbook</Citation></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008–2012. https://doi.org/10.1001/jama.283.15.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Excess Mortality Collaborators (2022) Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality. Lancet 399:1513–1536. https://doi.org/10.1016/s0140-6736(21)02796-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(21)02796-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Loney PL, Chambers LW, Bennett KJ et al (1998) Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can 19:170–176</Citation><ArticleIdList><ArticleId IdType="pubmed">10029513</ArticleId></ArticleIdList></Reference><Reference><Citation>Yovera-Aldana M, Velásquez-Rimachi V, Huerta-Rosario A et al (2021) Prevalence and incidence of diabetic peripheral neuropathy in Latin America and the Caribbean: a systematic review and meta-analysis. PLoS ONE 16:e0251642. https://doi.org/10.1371/journal.pone.0251642</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251642</ArticleId><ArticleId IdType="pubmed">33984049</ArticleId><ArticleId IdType="pmc">8118539</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-010-9491-z</ArticleId><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells GA, Shea B, O’Connell D et al (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp . Accessed 20 June 2023</Citation></Reference><Reference><Citation>DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. https://doi.org/10.1016/0197-2456(86)90046-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Barendregt JJ, Doi SA, Lee YY et al (2013) Meta-analysis of prevalence. J Epidemiol Community Health 67:974–978. https://doi.org/10.1136/jech-2013-203104</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech-2013-203104</ArticleId><ArticleId IdType="pubmed">23963506</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman MF, Tukey JW (1950) Transformations related to the angular and the square root. Ann Math Stat. 607–611. https://doi.org/10.1214/aoms/1177729756</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558. https://doi.org/10.1002/sim.1186</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbord RM, Higgins JP (2008) Meta-regression in Stata. Stata J 8:493–519. https://doi.org/10.1177/1536867X0800800403</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1536867X0800800403</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson SG, Higgins JP (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21:1559–1573. https://doi.org/10.1002/sim.1187</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1187</ArticleId><ArticleId IdType="pubmed">12111920</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634. https://doi.org/10.1136/bmj.315.7109.629</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId><ArticleId IdType="pmc">2127453</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco-Barrios K, Velasquez-Rimachi V, Navarro-Flores A et al (2023) Primary headache disorders in Latin America and the Caribbean: a meta-analysis of population-based studies. Cephalalgia 43:3331024221128265. https://doi.org/10.1177/03331024221128265</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024221128265</ArticleId><ArticleId IdType="pubmed">36606574</ArticleId></ArticleIdList></Reference><Reference><Citation>Schunemann H (2008) GRADE handbook for grading quality of evidence and strength of recommendation. Version 3.2. https://gdt.gradepro.org/app/handbook/handbook.html . Accessed 30 June 2023</Citation></Reference><Reference><Citation>Balshem H, Helfand M, Schünemann HJ et al (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64:401–406. https://doi.org/10.1016/j.jclinepi.2010.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.07.015</ArticleId><ArticleId IdType="pubmed">21208779</ArticleId></ArticleIdList></Reference><Reference><Citation>Acevedo L, Piñeres-Olave BE, Niño-Serna LF et al (2021) Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study). BMC Pediatr 21:516. https://doi.org/10.1186/s12887-021-02974-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-021-02974-9</ArticleId><ArticleId IdType="pubmed">34794410</ArticleId><ArticleId IdType="pmc">8600488</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Harbi S, Kazzaz YM, Uddin MS et al (2021) Clinical characteristics and outcomes of multisystem inflammatory syndrome in children (MIS-C): a national multicenter cohort in Saudi Arabia. Curr Pediatr Res 25:904–913</Citation></Reference><Reference><Citation>Bagri NK, Deepak RK, Meena S et al (2022) Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study. Rheumatol Int 42:477–484. https://doi.org/10.1007/s00296-021-05030-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-05030-y</ArticleId><ArticleId IdType="pubmed">34665296</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhooria GS, Kakkar S, Pooni PA et al (2021) Comparison of clinical features and outcome of dengue fever and multisystem inflammatory syndrome in children associated With COVID-19 (MIS-C). Indian Pediatr 58:951–954. https://doi.org/10.1007/s13312-021-2329-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13312-021-2329-9</ArticleId><ArticleId IdType="pubmed">34302327</ArticleId><ArticleId IdType="pmc">8549585</ArticleId></ArticleIdList></Reference><Reference><Citation>Haslak F, Barut K, Durak C et al (2021) Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children. Clin Rheumatol 40:4167–4178. https://doi.org/10.1007/s10067-021-05780-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05780-x</ArticleId><ArticleId IdType="pubmed">34089099</ArticleId><ArticleId IdType="pmc">8178032</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehra B, Pandey M, Gupta D et al (2021) COVID-19-associated multisystem inflammatory syndrome in children: a multicentric retrospective cohort study. Indian J Crit Care Med 25:1176–1182. https://doi.org/10.5005/jp-journals-10071-23996</Citation><ArticleIdList><ArticleId IdType="doi">10.5005/jp-journals-10071-23996</ArticleId><ArticleId IdType="pubmed">34916752</ArticleId><ArticleId IdType="pmc">8645810</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouldali N, Toubiana J, Antona D et al (2021) Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA 325:855–864. https://doi.org/10.1001/jama.2021.0694</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.0694</ArticleId><ArticleId IdType="pubmed">33523115</ArticleId></ArticleIdList></Reference><Reference><Citation>Sözeri B, Çağlayan Ş, Atasayan V et al (2021) The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center. Postgrad Med 133:994–1000. https://doi.org/10.1080/00325481.2021.1987732</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00325481.2021.1987732</ArticleId><ArticleId IdType="pubmed">34605352</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugunan S, Bindusha S, Geetha S et al (2021) Clinical profile and short-term outcome of children with SARS-CoV-2 related multisystem inflammatory syndrome (MIS-C) TREATED WITH PULSE METHYLPrednisolone. Indian Pediatr 58:718–722. https://doi.org/10.1007/s13312-021-2277-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13312-021-2277-4</ArticleId><ArticleId IdType="pubmed">33876782</ArticleId><ArticleId IdType="pmc">8384095</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagarro A, Cobos-Carrascosa E, Villaverde S et al (2022) Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children. Eur J Pediatr 181:1105–1115. https://doi.org/10.1007/s00431-021-04306-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04306-6</ArticleId><ArticleId IdType="pubmed">34738173</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari A, Balan S, Rauf A et al (2021) COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a hospital-based prospective cohort study from Kerala. India BMJ Paediatr Open 5:e001195. https://doi.org/10.1136/bmjpo-2021-001195</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjpo-2021-001195</ArticleId><ArticleId IdType="pubmed">34693035</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz OA, Sadiq M, Qureshi AU et al (2023) Short to midterm follow-up of multi-system inflammatory syndrome in children with special reference to cardiac involvement. Cardiol Young 33:371–379. https://doi.org/10.1017/s1047951122000828</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1047951122000828</ArticleId><ArticleId IdType="pubmed">35321771</ArticleId></ArticleIdList></Reference><Reference><Citation>Merckx J, Cooke S, El Tal T et al (2022) Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a multicentre cohort study. CMAJ 194:E513-e523. https://doi.org/10.1503/cmaj.210873</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.210873</ArticleId><ArticleId IdType="pubmed">35410860</ArticleId><ArticleId IdType="pmc">9001008</ArticleId></ArticleIdList></Reference><Reference><Citation>Go E, El Tal T, Tsoukas P, et al. (2021) Comparing apples to apples in post-COVID-associated multisystem inflammatory syndrome in children (MIS-C). https://doi.org/10.2139/ssrn.3894907</Citation></Reference><Reference><Citation>Lona-Reyes JC, Paredes-Casillas P, Sepúlveda-Marrón J et al (2021) Association of comorbidities and symptomatic infection and multisystemic inflammatory syndrome due to SARS-CoV-2 in children. Rev Chilena Infectol 38:605–612. https://doi.org/10.4067/s0716-10182021000500605</Citation><ArticleIdList><ArticleId IdType="doi">10.4067/s0716-10182021000500605</ArticleId><ArticleId IdType="pubmed">35506826</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannarino S, Raso I, Garbin M et al (2022) Cardiac dysfunction in multisystem inflammatory syndrome in children: an Italian single-center study. Ital J Pediatr 48:25. https://doi.org/10.1186/s13052-021-01189-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-021-01189-z</ArticleId><ArticleId IdType="pubmed">35135600</ArticleId><ArticleId IdType="pmc">8822778</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal P, Bathia JN, Ganguly M et al (2022) Cardiac evaluation in multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19. Indian Pediatr 59:339–340. https://doi.org/10.1007/s13312-022-2502-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13312-022-2502-9</ArticleId><ArticleId IdType="pubmed">35410972</ArticleId><ArticleId IdType="pmc">9065228</ArticleId></ArticleIdList></Reference><Reference><Citation>Phung NTN, Tran TT, Nguyen TH et al (2022) Cardiovascular injury and clinical features of multisystem inflammatory syndrome in children (MIS-C) related to Covid-19 in Vietnam. Pediatr Neonatol 63:569–574. https://doi.org/10.1016/j.pedneo.2022.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pedneo.2022.05.009</ArticleId><ArticleId IdType="pubmed">35871994</ArticleId><ArticleId IdType="pmc">9262642</ArticleId></ArticleIdList></Reference><Reference><Citation>Butters C, Abraham DR, Stander R et al (2022) The clinical features and estimated incidence of MIS-C in Cape Town. South Africa BMC Pediatr 22:241. https://doi.org/10.1186/s12887-022-03308-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-022-03308-z</ArticleId><ArticleId IdType="pubmed">35501710</ArticleId></ArticleIdList></Reference><Reference><Citation>Karunakar P, Ramamoorthy JG, Anantharaj A et al (2022) Clinical profile and outcomes of multisystem inflammatory syndrome in children (MIS-C): hospital-based prospective observational study from a tertiary care hospital in South India. J Paediatr Child Health 58:1964–1971. https://doi.org/10.1111/jpc.16129</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.16129</ArticleId><ArticleId IdType="pubmed">35869845</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra B, Mohapatra A, Patwari V et al (2022) Clinical profile and outcomes of multisystem inflammatory syndrome in children: a multicentric observational study. Cureus 14:e28821. https://doi.org/10.7759/cureus.28821</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.28821</ArticleId><ArticleId IdType="pubmed">36225458</ArticleId><ArticleId IdType="pmc">9535389</ArticleId></ArticleIdList></Reference><Reference><Citation>Angurana SK, Kumar V, Nallasamy K et al (2022) Clinico-laboratory profile, intensive care needs and short-term outcome of multisystem inflammatory syndrome in children (MIS-C): experience during first and second waves from North India. J Trop Pediatr 68:fmab055. https://doi.org/10.1093/tropej/fmac068</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/tropej/fmac068</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaxybayeva I, Boranbayeva R, Abdrakhmanova S et al (2022) Comparative analysis of clinical and laboratory data in children with multisystem inflammatory syndrome associated with SARS-CoV-2 in the Republic of Kazakhstan. Mediterr J Hematol Infect Dis 14:e2022064. https://doi.org/10.4084/mjhid.2022.064</Citation><ArticleIdList><ArticleId IdType="doi">10.4084/mjhid.2022.064</ArticleId><ArticleId IdType="pubmed">36119456</ArticleId><ArticleId IdType="pmc">9448265</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannattasio A, Orlando F, D’Anna C et al (2022) Distinctive phenotype of multisystem inflammatory syndrome in children associated with SARS-CoV-2 according to patients’ age: a monocentric experience. Children (Basel) 9:468. https://doi.org/10.3390/children9040468</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9040468</ArticleId><ArticleId IdType="pubmed">35455512</ArticleId></ArticleIdList></Reference><Reference><Citation>Abuhammour W, Yavuz L, Jain R et al (2022) Genetic and clinical characteristics of patients in the middle east with multisystem inflammatory syndrome in children. JAMA Netw Open 5:e2214985. https://doi.org/10.1001/jamanetworkopen.2022.14985</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.14985</ArticleId><ArticleId IdType="pubmed">35639375</ArticleId><ArticleId IdType="pmc">9157271</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostik MM, Bregel LV, Avrusin IS et al (2022) Heart involvement in multisystem inflammatory syndrome, associated with COVID-19 in children: the retrospective multicenter cohort data. Front Pediatr 10:829420. https://doi.org/10.3389/fped.2022.829420</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.829420</ArticleId><ArticleId IdType="pubmed">35311051</ArticleId><ArticleId IdType="pmc">8924435</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapoor R, Chandra T, Singh CP et al (2023) Multisystem inflammatory syndrome in children (MIS-C) related to SARS-CoV-2 and 1-year follow-up. Indian J Pediatr 90:1008–1012. https://doi.org/10.1007/s12098-022-04385-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12098-022-04385-9</ArticleId><ArticleId IdType="pubmed">36482236</ArticleId></ArticleIdList></Reference><Reference><Citation>Pérez López P, Carvajal Duque D, Salgado García DM et al (2022) Multisystemic inflammatory syndrome in children from the South of Colombia: one year of experience. Front Pediatr 10:838922. https://doi.org/10.3389/fped.2022.838922</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.838922</ArticleId><ArticleId IdType="pubmed">35450106</ArticleId><ArticleId IdType="pmc">9016331</ArticleId></ArticleIdList></Reference><Reference><Citation>Grama A, Căinap SS, Mititelu A et al (2022) Multisystemic inflammatory syndrome in children, a disease with too many faces: a single-center experience. J Clin Med 11:5256. https://doi.org/10.3390/jcm11185256</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11185256</ArticleId><ArticleId IdType="pubmed">36142902</ArticleId><ArticleId IdType="pmc">9504807</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcanti A, Islabão A, Magalhães C et al (2022) Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): a Brazilian cohort. Adv Rheumatol 62:6. https://doi.org/10.1186/s42358-022-00237-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42358-022-00237-4</ArticleId><ArticleId IdType="pubmed">35189972</ArticleId><ArticleId IdType="pmc">8860252</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy N, Koppel JH, Kaplan O et al (2022) Severity and incidence of multisystem inflammatory syndrome in children during 3 SARS-CoV-2 pandemic waves in Israel. JAMA 327:2452–2454. https://doi.org/10.1001/jama.2022.8025</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.8025</ArticleId><ArticleId IdType="pubmed">35588048</ArticleId><ArticleId IdType="pmc">9121298</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarado-Gamarra G, Del Aguila O, Dominguez-Rojas J et al (2022) Clinical phenotypes of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19. Andes Pediatr 93:841–850. https://doi.org/10.32641/andespediatr.v93i6.4084</Citation><ArticleIdList><ArticleId IdType="doi">10.32641/andespediatr.v93i6.4084</ArticleId><ArticleId IdType="pubmed">37906801</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantarutti N, Battista V, Adorisio R et al (2021) Cardiac manifestations in children with SARS-COV-2 infection: 1-year pediatric multicenter experience. Children (Basel) 8:717. https://doi.org/10.3390/children8080717</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children8080717</ArticleId><ArticleId IdType="pubmed">34438608</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud S, Fouda EM, Kotby A et al (2021) The “golden hours” algorithm for the management of the multisystem inflammatory syndrome in children (MIS-C). Glob Pediatr Health 8:2333794x21990339. https://doi.org/10.1177/2333794x21990339</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2333794x21990339</ArticleId><ArticleId IdType="pubmed">33614843</ArticleId><ArticleId IdType="pmc">7868488</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolunay O, Çelik Ü, Arslan İ et al (2021) Multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19: a case series experience in a tertiary care hospital of Southern Turkey. J Trop Pediatr 67:fmab050. https://doi.org/10.1093/tropej/fmab050</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/tropej/fmab050</ArticleId><ArticleId IdType="pubmed">34028528</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwikowska KM, Okarska-Napierała M, Dudek N et al (2021) Distinct characteristics of multisystem inflammatory syndrome in children in Poland. Sci Rep 11:23562. https://doi.org/10.1038/s41598-021-02669-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-02669-2</ArticleId><ArticleId IdType="pubmed">34876594</ArticleId><ArticleId IdType="pmc">8651720</ArticleId></ArticleIdList></Reference><Reference><Citation>Atasayan V, Akbay ÖP, Çağlayan Ş et al (2023) Cardiac involvement in multisystem inflammatory syndrome in children: single-centre experience. Cardiol Young 33:1117–1123. https://doi.org/10.1017/s1047951122002220</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1047951122002220</ArticleId><ArticleId IdType="pubmed">35837680</ArticleId></ArticleIdList></Reference><Reference><Citation>Stasiak A, Kędziora P, Kierzkowska B et al (2022) Changes in the cardiovascular system in children with pediatric multisystem inflammatory syndrome temporally associated with COVID-19 - A single center experience. Int J Cardiol 361:126–133. https://doi.org/10.1016/j.ijcard.2022.05.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2022.05.030</ArticleId><ArticleId IdType="pubmed">35577166</ArticleId><ArticleId IdType="pmc">9106401</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostami-Maskopaee F, Ladomenou F, Razavi-Amoli SK et al (2022) Clinical characteristics and outcomes of the multisystem inflammatory syndrome in children (MIS-C) following COVID-19 infection in Iran: a multicenter study. PLoS ONE 17:e0274104. https://doi.org/10.1371/journal.pone.0274104</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0274104</ArticleId><ArticleId IdType="pubmed">36137147</ArticleId><ArticleId IdType="pmc">9498965</ArticleId></ArticleIdList></Reference><Reference><Citation>Yashaswini K, Lalitha AV, Naresh Kanna GS (2022) Clinical profile of multisystem inflammatory syndrome in children associated with SARS-CoV-2 admitted to pediatric intensive care unit. J Pediatr Intensive Care. https://doi.org/10.1055/s-0042-1750300</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1750300</ArticleId></ArticleIdList></Reference><Reference><Citation>Kıymet E, Böncüoğlu E, Şahinkaya Ş et al (2021) A comparative study of children with MIS-C between admitted to the pediatric intensive care unit and pediatric ward: a one-year retrospective study. J Trop Pediatr 67:fmab104. https://doi.org/10.1093/tropej/fmab104</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/tropej/fmab104</ArticleId><ArticleId IdType="pubmed">34931251</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira de Melo J, Valsassina R, Garcia AM et al (2022) Multisystem inflammatory syndrome in children associated with COVID-19 in a tertiary level hospital in Portugal. Acta Med Port 35:881–890. https://doi.org/10.20344/amp.17797</Citation><ArticleIdList><ArticleId IdType="doi">10.20344/amp.17797</ArticleId><ArticleId IdType="pubmed">35639579</ArticleId></ArticleIdList></Reference><Reference><Citation>Romanova O, Kolomiets N, Savitski D, et al. (2022) Multisystem inflammatory syndrome in children course amid COVID-19 pandemic in the Rebublic of Belarus. medRxiv:2022.2010. 2014.22280869. https://doi.org/10.1101/2022.10.14.22280869</Citation></Reference><Reference><Citation>Savas Sen Z, Tanir G, Gumuser Cinni R et al (2022) Multisystem inflammatory syndrome in children during severe acute respiratory syndrome coronavirus-2 pandemic in Turkey: a single-centre experience. J Paediatr Child Health 58:129–135. https://doi.org/10.1111/jpc.15674</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.15674</ArticleId><ArticleId IdType="pubmed">34343373</ArticleId></ArticleIdList></Reference><Reference><Citation>Laverty M, Salvadori M, Squires SG et al (2021) Multisystem inflammatory syndrome in children in Canada. Can Commun Dis Rep 47:461–465. https://doi.org/10.14745/ccdr.v47i11a03</Citation><ArticleIdList><ArticleId IdType="doi">10.14745/ccdr.v47i11a03</ArticleId><ArticleId IdType="pubmed">35356073</ArticleId><ArticleId IdType="pmc">8896683</ArticleId></ArticleIdList></Reference><Reference><Citation>Menchaca-Aguayo H, Alpizar-Rodriguez D, Ramos-Tiñini P et al (2022) Multisystem inflammatory syndrome in children related to COVID-19: Data from a Mexican national referral children’s hospital. Front Pediatr 10:949965. https://doi.org/10.3389/fped.2022.949965</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.949965</ArticleId><ArticleId IdType="pubmed">36034559</ArticleId><ArticleId IdType="pmc">9411964</ArticleId></ArticleIdList></Reference><Reference><Citation>Elilarasi S, Poovazhagi V, Kumaravel G et al (2022) Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. Indian J Pediatr 89:879–884. https://doi.org/10.1007/s12098-021-03954-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12098-021-03954-8</ArticleId><ArticleId IdType="pubmed">34817811</ArticleId></ArticleIdList></Reference><Reference><Citation>Thom K, Kahl B, Wagner T et al (2022) SARS-CoV-2 Associated pediatric inflammatory multisystem syndrome with a high prevalence of myocarditis - a multicenter evaluation of clinical and laboratory characteristics, treatment and outcome. Front Pediatr 10:896252. https://doi.org/10.3389/fped.2022.896252</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.896252</ArticleId><ArticleId IdType="pubmed">35757128</ArticleId><ArticleId IdType="pmc">9227661</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhaliwal M, Raghunathan V, Maheshwari P et al (2022) Severity and cardiac involvement in multisystem inflammatory syndrome in children. Indian J Pediatr 89:1040–1044. https://doi.org/10.1007/s12098-022-04328-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12098-022-04328-4</ArticleId><ArticleId IdType="pubmed">36028606</ArticleId><ArticleId IdType="pmc">9417928</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin B, DeWitt PE, Russell S et al (2022) Characteristics, outcomes, and severity risk factors associated with SARS-CoV-2 infection among children in the US National COVID Cohort Collaborative. JAMA Netw Open 5:e2143151. https://doi.org/10.1001/jamanetworkopen.2021.43151</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.43151</ArticleId><ArticleId IdType="pubmed">35133437</ArticleId><ArticleId IdType="pmc">8826172</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein LR, Tenforde MW, Friedman KG et al (2021) Characteristics and outcomes of us children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA 325:1074–1087. https://doi.org/10.1001/jama.2021.2091</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.2091</ArticleId><ArticleId IdType="pubmed">33625505</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufort EM, Koumans EH, Chow EJ et al (2020) Multisystem inflammatory syndrome in children in New York State. N Engl J Med 383:347–358. https://doi.org/10.1056/NEJMoa2021756</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021756</ArticleId><ArticleId IdType="pubmed">32598830</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyama M, Vargas L, Ticliahuanca S et al (2022) Regional clustering and waves patterns due to COVID-19 by the index virus and the lambda/gamma, and delta/omicron SARS-CoV-2 variants in Peru. Gates Open Res 6:74. https://doi.org/10.12688/gatesopenres.13644.2</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/gatesopenres.13644.2</ArticleId><ArticleId IdType="pubmed">38045771</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorg AL, Hufnagel M, Doenhardt M et al (2022) Risk for severe outcomes of COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany. Eur J Pediatr 181:3635–3643. https://doi.org/10.1007/s00431-022-04587-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04587-5</ArticleId><ArticleId IdType="pubmed">35962242</ArticleId><ArticleId IdType="pmc">9374569</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambrano LD, Newhams MM, Olson SM et al (2022) Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12–18 years - United States, July-December 2021. MMWR Morb Mortal Wkly Rep 71:52–58. https://doi.org/10.15585/mmwr.mm7102e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7102e1</ArticleId><ArticleId IdType="pubmed">35025852</ArticleId><ArticleId IdType="pmc">8757620</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood R, Yan H, Talawila Da Camara N et al (2022) Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis. EClinicalMedicine 44:101287. https://doi.org/10.1016/j.eclinm.2022.101287</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101287</ArticleId><ArticleId IdType="pubmed">35169689</ArticleId><ArticleId IdType="pmc">8832134</ArticleId></ArticleIdList></Reference><Reference><Citation>Son MBF, Burns JC, Newburger JW (2023) A new definition for multisystem inflammatory syndrome in children. Pediatrics 151:e2022060302. https://doi.org/10.1542/peds.2022-060302</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-060302</ArticleId><ArticleId IdType="pubmed">36624565</ArticleId></ArticleIdList></Reference><Reference><Citation>Day-Lewis M, Berbert L, Baker A et al (2024) Updated case definition of MIS-C and implications for clinical care. Pediatrics 153:e2023063259. https://doi.org/10.1542/peds.2023-063259</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2023-063259</ArticleId><ArticleId IdType="pubmed">38204335</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>